Stock Movers
Stock Movers

Jun 30, 2026 · 6 min

AI fears sink Concentrix while lawmakers target Merck and AbbVie trials

Concentrix Tumbles; AVAV Soars; Nike to Report

Investors are grappling with the immediate financial impacts of AI disruption and the growing geopolitical risks of conducting pharmaceutical research in China.

3 key takeaways
  1. 1Concentrix shares plummeted 24 percent after lowering its outlook due to fears that AI is reducing customer service outsourcing demand.
  2. 2Bipartisan US lawmakers opened national security investigations into drugmakers Merck and AbbVie regarding clinical trials conducted in China.
  3. 3Digital Realty announced a 3.5 billion dollar deal to acquire Blackstone data center stakes, funded by a dilutive secondary offering.

Don't miss

Dan Curtis details the 24 percent drop in Concentrix shares, signaling a major market reaction to AI replacing traditional customer service outsourcing.

The brief

The rise of artificial intelligence is beginning to reshape corporate valuations, as outsourcing giant Concentrix sees its shares plunge 24 percent on fears that automated customer service is rapidly shrinking demand for human agents.

While tech disruption hits service providers, national security concerns are squeezing the pharmaceutical sector, with US lawmakers launching bipartisan investigations into Merck and AbbVie over clinical trials conducted in China.

In the infrastructure space, Digital Realty announced a massive 3.5 billion dollar acquisition of Blackstone data center stakes in Northern Virginia, though a dilutive secondary offering sent its stock lower despite the AI-driven demand.

What was said on this episode

4 statements · 2 positive · 2 negative

  1. Dan Curtison Concentrix IX SuitePositive1:43

    Concentrix’s AI-integrated IX Suite is on track to reach $120 million revenue by year-end.

    “It noted that its IX Suite, which integrates AI, is on track to double to 120 million in revenue by the”

    Listen at 1:43

  2. Dan Curtison Clinical trials in XinjiangNegative2:46

    Chinese researchers documented informed-consent lapses in clinical trials in Xinjiang.

    “they say that Chinese researchers have documented lapses in securing informed consent from trial participants in that region”

    Listen at 2:46

  3. Dan Curtison Digital Realty secondary offeringNegative3:35

    Digital Realty’s secondary offering will cause some shareholder dilution.

    “That $2.3 billion in shares is coming through a secondary offering which is going to add a little bit of dilution”

    Listen at 3:35

  4. Dan Curtison Northern Virginia data center hubPositive3:56

    Northern Virginia is the leading data-center hub in the United States.

    “North Virginia is the lead data center hub in the US”

    Listen at 3:56

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Featuring

Listen to the full episode and explore every guest, topic, and moment on PodLume.

What is PodLume?

PodLume turns podcasts into searchable knowledge. AI-decoded transcripts, identified guests and topics, smart highlights, and cross-show search across the world’s best conversations — all in your pocket.

AI fears sink Concentrix while lawmakers target Merck and AbbVie trials | PodLume